Non-vascular stents are mainly shielded with a polymeric film or membrane to avoid ingrowth of adjacent tissues through stent mesh. Drugs for suppression of hyperplastic malignant or benign tissues can be integrated into polymeric materials. Materials widely used in stent covering include polyurethane, silicon, and expanded polytrafluoroethylene (e-PTFE). Stents in non-vascular applications are a standard treatment for removal of occluding tumors in the gastrointestinal system.

Dynamics

Major factor driving growth of the non-vascular stents market is increasing application of stents in gastrointestinal and glaucoma-related disorders. Rising incidence of urological problems, gastrointestinal diseases, glaucoma, and other conditions, are expected to increase the demand for non-vascular stents. For instance, in the U.S., gastrointestinal hemorrhage was the most common condition leading to hospitalization, with around 500,000 discharges recorded in 2012. Growing prevalence of gastrointestinal cancer is expected be a major factor driving growth of the global non-vascular stents market. Increasing respiratory and gastro-urological morbidities is increasing the demand for non-vascular stents, as these stents help maintain vessel patency. Furthermore, growing demand for minimally invasive procedures, which enable faster recovery, cause less pain, and involve shorter hospital stays, is expected to boost growth of the non-vascular stents market in the near future. Over the recent past, the demand for such stents is witnessing increasing in ophthalmic and neural applications. Both application areas—eyes and the brain—are sensitive to implantation of devices. Non-vascular stents, being a minimally invasive and accurate procedure, is rapidly being adopted for these applications. Smaller stents, known as a micro-stents, are being developed for application in areas related to eyes and the brain.  

Key features of the study

• This report provides in-depth analysis of non-vascular stents market and provides market size (USD Mn) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2026 – 2033), considering 2025 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategy adopted by the leading players
• It profiles leading players in the global non-vascular stents market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments and strategies, and future plans
• Key companies covered as a part of this study include Allium Medical, Boston Scientific, C.R. Bard, ELLA-CS, s.r.o, EndoChoice, Merit Endotek, Taewoong Medical, and Xlumena, Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
• The global non-vascular stents market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the non-vascular stents market

 Market Segmentation

• By Product Type Insights (Revenue, USD Mn, 2021 - 2033)
  • Urological Stents
  • Gastrointestinal Stents
  • Pulmonary Or Airway Stents
  • Others
• By Region Insights (Revenue, USD Mn, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
• Key Players 
  • Allium Medical
  • Boston Scientific
  • R. Bard
  • ELLA-CS
  • R.O
  • EndoChoice
  • Merit Endotek
  • Taewoong Medical
  • Xlumena